D. Dincol Et Al. , "Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP," MEDICAL ONCOLOGY , vol.27, no.3, pp.942-945, 2010
Dincol, D. Et Al. 2010. Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. MEDICAL ONCOLOGY , vol.27, no.3 , 942-945.
Dincol, D., Buyukcelik, A., Dogan, M., AKBULUT, H., Samur, M., DEMİRKAZIK, A., ... ÇAY ŞENLER, F.(2010). Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP. MEDICAL ONCOLOGY , vol.27, no.3, 942-945.
Dincol, Dilek Et Al. "Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP," MEDICAL ONCOLOGY , vol.27, no.3, 942-945, 2010
Dincol, Dilek Et Al. "Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP." MEDICAL ONCOLOGY , vol.27, no.3, pp.942-945, 2010
Dincol, D. Et Al. (2010) . "Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP." MEDICAL ONCOLOGY , vol.27, no.3, pp.942-945.
@article{article, author={Dilek Dincol Et Al. }, title={Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP}, journal={MEDICAL ONCOLOGY}, year=2010, pages={942-945} }